INAB | IN8bio, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.2303 - 0.2552
52 Week Range	0.2170 - 1.9300
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	1,246,480
Average Volume	1,218,493
Shares Outstanding	72,483,200
Market Cap	18,033,820
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-07-30

Valuation
Profitability
Growth
Health
P/E Ratio	-0.34
Forward P/E Ratio	N/A
EPS	-0.74
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	39
Country	USA
Website	INAB

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.

INAB's peers: ANIX, ANNX, ANVS, APLT, APTO, CGTX, CNTX, CRDF, CUE, GANX, IMNM, IMRN, RVPH, LTRN, GRCL, INMB, PYPD, ZURA, ICVX, WVE, TFFP, LIFE, PALI, CFRX, ALLR, CNSP, WINT, IPA, NBTX, NERV, PSTX, PMN, SPRY, COYA

*Chart delayed

Analyzing fundamentals for INAB we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see INAB Fundamentals page.

Watching at INAB technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on INAB Technicals page.